The COVID-19 Seroprevalence Studies Hub, known as COVID-19 SeroHub, is an online dashboard intended to help researchers and policymakers monitor studies of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence in the United States. These types of studies use blood tests to identify the proportion of people in the population who possess antibodies to SARS-CoV-2. Studies included to date have been identified via literature search and review of NIH portfolios.
This site was available on the date of the last automated link check. (2025/06/16)
Identifier | URL:https://episphere.github.io/serohub/ |
Type | data set |
Biological Scale | population |
Collection End Date | |
Language | English |
Topics | |
Geographical Scope | United States |
Geographical Resolution | State |
Start Date | 2020/03/01 |
End Date | |
Version | unspecified |
Accessible For Free | TRUE |
License | unspecified |
Rights | https://www.cancer.gov/policies/disclaimer |
HTTP Status Code | 200 |
HTTP Checked On | 2025/06/16 |